The Role of Serotonergic Mechanisms in Inhibition of Isolation-induced Aggression in Male Mice
Overview
Authors
Affiliations
The role of serotonergic (5-HT) receptor subtypes in mediation of aggressive behaviour in isolated male mice has been studied. Increase of attack latency was used as a simple measure of antiaggressive behaviour. 5-HT1A agonists (BAY R 1531, 8-OHDPAT, flesinoxan, gepirone, 5MeO DMT, buspirone, ipsapirone, BMY 14802) completely inhibit the aggressive behaviour irrespective of their intrinsic activities. Also the putative antagonists spiroxatrine and NAN 190 as well as the non-selective 5-HT1 agonists RU 24969, TFMPP, mCPP and eltoprazine have an antiaggressive effect. The mixed 5-HT1A and beta-adrenoceptor antagonists (-)-alprenolol and pindolol are ineffective and do not inhibit the effect of 8-OHDPAT. Neither does the non-selective 5-HT antagonist metergoline. The antiaggressive effect correlates with 5-HT1A receptor affinity in vitro and with generalization to the 8-OHDPAT-induced discriminative stimulus. The selective 5-HT uptake inhibitor citalopram does not inhibit aggressive behaviour. The 5-HT2 agonist DOI has an antiaggressive effect only at high doses, whereas the 5-HT2 antagonist ritanserin and the 5-HT3 antagonist ondansetron are ineffective. Prazosin (alpha 1-adrenoceptor antagonist), clonidine (alpha 2-adrenoceptor agonist), clenbuterol (beta-adrenoceptor agonist), ketanserin (5-HT2 receptor and alpha 1-adrenoceptor antagonist), clozapine and (-)-octoclothepin (dopamine (DA), 5-HT2 receptor and alpha 1-adrenoceptor antagonist) all show an antiaggressive effect. SCH 23390 (DA D1 receptor antagonist) and emonapride (DA D2 receptor antagonist) are ineffective. In conclusion, 5-HT1A receptors are involved in mediation of isolation-induced aggressive behaviour in mice. The involvement of other 5-HT receptor subtypes needs further clarification. The adrenergic system may also be involved.(ABSTRACT TRUNCATED AT 250 WORDS)
Neural cell-types and circuits linking thermoregulation and social behavior.
Rogers J, Vandendoren M, Prather J, Landen J, Bedford N, Nelson A Neurosci Biobehav Rev. 2024; 161():105667.
PMID: 38599356 PMC: 11163828. DOI: 10.1016/j.neubiorev.2024.105667.
Karim A, Anwar F, Saleem U, Fatima S, Ismail T, Obaidullah A Metab Brain Dis. 2023; 38(7):2255-2267.
PMID: 37458892 DOI: 10.1007/s11011-023-01258-8.
Anesthetic-loaded nanodroplets with focused ultrasound reduces agitation in Alzheimer's mice.
Venetucci Gouveia F, Lea-Banks H, Aubert I, Lipsman N, Hynynen K, Hamani C Ann Clin Transl Neurol. 2023; 10(4):507-519.
PMID: 36715553 PMC: 10109287. DOI: 10.1002/acn3.51737.
Moskaliuk V, Kozhemyakina R, Khomenko T, Volcho K, Salakhutdinov N, Kulikov A Int J Mol Sci. 2023; 24(2).
PMID: 36674499 PMC: 9867021. DOI: 10.3390/ijms24020983.
Popova N, Tsybko A, Naumenko V Int J Mol Sci. 2022; 23(15).
PMID: 35955946 PMC: 9369404. DOI: 10.3390/ijms23158814.